Literature DB >> 19262595

A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic response.

M W Drummond, N Heaney, J Kaeda, F E Nicolini, R E Clark, G Wilson, P Shepherd, J Tighe, L McLintock, T Hughes, T L Holyoake.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19262595     DOI： 10.1038/leu.2009.43

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  17 in total

Review 1.  Targeting leukemic stem cells by breaking their dormancy.

Authors:  Marieke Alida Gertruda Essers; Andreas Trumpp
Journal:  Mol Oncol       Date:  2010-06-09       Impact factor: 6.603

2.  Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis.

Authors:  Fabrizio Vianello; Federica Villanova; Veronica Tisato; Stefania Lymperi; Ka-Kei Ho; Ana R Gomes; David Marin; Dominique Bonnet; Jane Apperley; Eric W-F Lam; Francesco Dazzi
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

3.  Awakening dormant haematopoietic stem cells.

Authors:  Andreas Trumpp; Marieke Essers; Anne Wilson
Journal:  Nat Rev Immunol       Date:  2010-03       Impact factor: 53.106

Review 4.  Critical molecular pathways in cancer stem cells of chronic myeloid leukemia.

Authors:  Y Chen; C Peng; C Sullivan; D Li; S Li
Journal:  Leukemia       Date:  2010-06-24       Impact factor: 11.528

Review 5.  Alternative approaches to eradicating the malignant clone in chronic myeloid leukemia: tyrosine-kinase inhibitor combinations and beyond.

Authors:  Wesam Ahmed; Richard A Van Etten
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2013

Review 6.  Curing chronic myeloid leukemia.

Authors:  Delphine Rea; Philippe Rousselot; Joelle Guilhot; François Guilhot; François-Xavier Mahon
Journal:  Curr Hematol Malig Rep       Date:  2012-06       Impact factor: 3.952

Review 7.  Stem cell quiescence.

Authors:  Ling Li; Ravi Bhatia
Journal:  Clin Cancer Res       Date:  2011-05-18       Impact factor: 12.531

Review 8.  The Ph-positive and Ph-negative myeloproliferative neoplasms: some topical pre-clinical and clinical issues.

Authors:  Richard A Van Etten; Steffen Koschmieder; Francois Delhommeau; Danilo Perrotti; Tessa Holyoake; Animesh Pardanani; Ruben Mesa; Tony Green; Amr R Ibrahim; Tariq Mughal; Robert Peter Gale; John Goldman
Journal:  Haematologica       Date:  2011-01-17       Impact factor: 9.941

9.  New experimental and theoretical investigations of hematopoietic stem cells and chronic myeloid leukemia.

Authors:  Ingo Roeder; Mark d'Inverno
Journal:  Blood Cells Mol Dis       Date:  2009-05-02       Impact factor: 3.039

10.  Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib.

Authors:  Jasmine Foo; Mark W Drummond; Bayard Clarkson; Tessa Holyoake; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2009-09-11       Impact factor: 4.475
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.